received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
FDA GRAS status applies only to oral fat-loss use, not to injection for joint repair
Mild side effects, such as soreness at the injection site, are rare
First, you need to understand the financial part of it
Indications: Vitamin B12 deficiency, energy support, anemia, neuropathy, cognitive function, immune health